Emerging therapies and respiratory infections: focus on the impact of immunosuppressants and immunotherapies

Caroline M Patterson*, Timothy Shaw, Vicky Gerovasili, Usman Khatana, Ricardo J Jose

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
1 Downloads (Pure)

Abstract

Host defences to infection are based upon an integrated system of physical and biochemical barriers, innate and adaptive immunity. Weakness in any of these defensive elements leads to increased susceptibility to specific pathogens. Understanding how medical therapies disrupt host defences is key to the successful prevention, diagnosis and management of respiratory infection in the immunocompromised host.
Original languageEnglish
Article number100015
JournalClinical Medicine, Journal of the Royal College of Physicians of London
Volume24
Issue number1
Early online date17 Jan 2024
DOIs
Publication statusPublished - 21 Feb 2024

Keywords

  • Adaptive Immunity
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents - therapeutic use
  • Immunosupression
  • Immunotherapy
  • Respiratory Tract Infections - drug therapy
  • Respiratory infection

Fingerprint

Dive into the research topics of 'Emerging therapies and respiratory infections: focus on the impact of immunosuppressants and immunotherapies'. Together they form a unique fingerprint.

Cite this